HCA Healthcare Inc (NYSE: HCA) closed the day trading at $340.54 up 1.86% from the previous closing price of $334.32. In other words, the price has increased by $1.86 from its previous closing price. On the day, 1.87 million shares were traded. HCA stock price reached its highest trading level at $341.19 during the session, while it also had its lowest trading level at $331.7.
Ratios:
For a better understanding of HCA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 87.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.23. For the most recent quarter (mrq), Quick Ratio is recorded 0.86 and its Current Ratio is at 0.98.
On July 16, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $394.
Wells Fargo Upgraded its Underweight to Equal Weight on May 29, 2025, while the target price for the stock was maintained at $385.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Foster Jon M sold 15,698 shares for $369.32 per share. The transaction valued at 5,797,661 led to the insider holds 12,646 shares of the business.
Foster Jon M bought 15,698 shares of HCA for $5,797,660 on May 13 ’25. On Feb 14 ’25, another insider, Berres Jennifer, who serves as the SVP & Chief Human Res. Officer of the company, sold 9,533 shares for $322.59 each. As a result, the insider received 3,075,240 and left with 15,412 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCA now has a Market Capitalization of 81925070848 and an Enterprise Value of 130961375232. As of this moment, HCA’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.30, and their Forward P/E ratio for the next fiscal year is 12.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13. Its current Enterprise Value per Revenue stands at 1.801 whereas that against EBITDA is 9.032.
Stock Price History:
The Beta on a monthly basis for HCA is 1.38, which has changed by -0.05758959 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, HCA has reached a high of $417.14, while it has fallen to a 52-week low of $289.98. The 50-Day Moving Average of the stock is -8.87%, while the 200-Day Moving Average is calculated to be -1.27%.
Shares Statistics:
Over the past 3-months, HCA traded about 1.48M shares per day on average, while over the past 10 days, HCA traded about 1838340 shares per day. A total of 240.57M shares are outstanding, with a floating share count of 170.51M. Insiders hold about 29.12% of the company’s shares, while institutions hold 65.65% stake in the company. Shares short for HCA as of 1752537600 were 3888909 with a Short Ratio of 2.62, compared to 1749772800 on 4638449. Therefore, it implies a Short% of Shares Outstanding of 3888909 and a Short% of Float of 2.29.
Dividends & Splits
HCA’s forward annual dividend rate is 2.76, up from 2.76 a year ago. Against a Trailing Annual Dividend Yield of 0.008255564The stock’s 5-year Average Dividend Yield is 0.76.
